Cargando…

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma

Identifying novel prognostic biomarkers for hepatocellular carcinoma (HCC) and then, develop an effective individualized treatment strategy remain extremely warranted. The prognostic role of sulfiredoxin‐1(SRXN1), an antioxidant enzyme, remains unknown in HCC. This study aimed to explore the prognos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Qian‐Wen, Zhang, Shi‐Long, Guo, Meng‐Zhou, Yuan, Fei‐Fei, Sun, Jia‐Lei, Qi, Feng, Wang, Li‐Shun, Yang, Bi‐Wei, Xia, Jing‐Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666720/ https://www.ncbi.nlm.nih.gov/pubmed/32955798 http://dx.doi.org/10.1002/cam4.3430

Ejemplares similares

Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma
por: Liang, Yuelong, et al.
Publicado: (2017)

The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
por: Sellers, Cortlandt M., et al.
Publicado: (2021)

A distinctively expressed long noncoding RNA, RP11‐466I1.1, may serve as a prognostic biomarker in hepatocellular carcinoma
por: Zhang, Junyong, et al.
Publicado: (2018)

Prognostic and predicted significance of Ubqln2 in patients with hepatocellular carcinoma
por: Luo, Yuan‐Deng, et al.
Publicado: (2020)

The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2018)

The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively
por: Li, Wen‐Qian, et al.
Publicado: (2021)

Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
por: Wu, Chengde, et al.
Publicado: (2020)

Construction of a disease‐specific lncRNA‐miRNA‐mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2020)

Role of sulfiredoxin in systemic diseases influenced by oxidative stress
por: Ramesh, Asha, et al.
Publicado: (2014)

Specificity of Human Sulfiredoxin for Reductant and Peroxiredoxin Oligomeric State
por: Forshaw, Tom E., et al.
Publicado: (2021)

The prognostic value of TPM1–4 in hepatocellular carcinoma
por: Tian, Zhihui, et al.
Publicado: (2021)

In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma
por: Lvu, Wen, et al.
Publicado: (2020)

Increased sulfiredoxin-1 levels as compensatory mechanism against reactive oxygen species in women with gestational diabetes mellitus
por: Tatar, Burak, et al.
Publicado: (2021)

AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma
por: Xiao, Jingchuan, et al.
Publicado: (2021)

Seven immune‐related genes prognostic power and correlation with tumor‐infiltrating immune cells in hepatocellular carcinoma
por: Liu, Tiantian, et al.
Publicado: (2020)

Prognostic value of aberrantly expressed methylation genes in human hepatocellular carcinoma
por: Zhen, Limin, et al.
Publicado: (2020)

A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers
por: Lai, Changchun, et al.
Publicado: (2021)

Albumin‐to‐fibrinogen ratio as a promising biomarker to predict clinical outcome of non‐small cell lung cancer individuals
por: Li, Shu‐Qi, et al.
Publicado: (2018)

Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus‐related hepatocellular carcinoma
por: Yu, Tingdong, et al.
Publicado: (2017)

Apigenin Induced Apoptosis by Downregulating Sulfiredoxin Expression in Cutaneous Squamous Cell Carcinoma
por: Wang, Wenhua, et al.
Publicado: (2022)

Systematic analyses of a novel lncRNA‐associated signature as the prognostic biomarker for Hepatocellular Carcinoma
por: Sui, Jing, et al.
Publicado: (2018)

The mitochondrial hinge protein, UQCRH, is a novel prognostic factor for hepatocellular carcinoma
por: Park, Eun‐Ran, et al.
Publicado: (2017)

CLEC1B is a Promising Prognostic Biomarker and Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Xiaoliang, et al.
Publicado: (2022)

Expression of human Krüppel‐like factor 3 in peripheral blood as a promising biomarker for acute leukemia
por: Yan, Miao, et al.
Publicado: (2020)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

Development and validation of LRP1B mutation-associated prognostic model for hepatocellular carcinoma
por: Xu, Jian, et al.
Publicado: (2021)

Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma
por: Tian, Wei, et al.
Publicado: (2023)

Independent prognostic factors for posttransplant survival in hepatocellular carcinoma patients undergoing liver transplantation
por: Xing, Minzhi, et al.
Publicado: (2016)

Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Kim, Chang Gon, et al.
Publicado: (2019)

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis
por: Hiraoka, Atsushi, et al.
Publicado: (2019)

Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery
por: Hou, Gui‐min, et al.
Publicado: (2021)

Characterization of plant sulfiredoxin and role of sulphinic form of 2-Cys peroxiredoxin
por: Iglesias-Baena, Iván, et al.
Publicado: (2010)

Sulfiredoxin as a Potential Therapeutic Target for Advanced and Metastatic Prostate Cancer
por: Barquilha, Caroline N., et al.
Publicado: (2020)

p53 drives necroptosis via downregulation of sulfiredoxin and peroxiredoxin 3
por: Rius-Pérez, Sergio, et al.
Publicado: (2022)

Tissue-derived exosome proteomics identifies promising diagnostic biomarkers for esophageal cancer
por: Rao, Dingyu, et al.
Publicado: (2023)

PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma
por: Wang, Pusen, et al.
Publicado: (2020)

Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer
por: Ibrahim, Joe, et al.
Publicado: (2019)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma
por: Ding, Yuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tv5vr0c5jv8jptbj1g39drif3h